Literature DB >> 19011422

Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand.

Pasiri Sithinamsuwan, Sirichai Punthanamongkol, Victor Valcour, Satrirat Onsanit, Samart Nidhinandana, Sataporn Thitivichianlert, Cecilia Shikuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19011422      PMCID： PMC3635535          DOI： 10.1097/QAI.0b013e318186eb03

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  13 in total

1.  Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

Authors:  Kenneth A Lichtenstein; Carl Armon; Anna Baron; Anne C Moorman; Kathleen C Wood; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2004-12-06       Impact factor: 9.079

Review 2.  HIV-associated neuropathic pain: epidemiology, pathophysiology and management.

Authors:  Susama Verma; Lydia Estanislao; David Simpson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  HIV neuropathy natural history cohort study: assessment measures and risk factors.

Authors:  D M Simpson; D Kitch; S R Evans; J C McArthur; D M Asmuth; B Cohen; K Goodkin; M Gerschenson; Y So; C M Marra; R Diaz-Arrastia; S Shriver; L Millar; D B Clifford
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

4.  Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey.

Authors:  Y T So; D M Holtzman; D I Abrams; R K Olney
Journal:  Arch Neurol       Date:  1988-09

5.  Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection.

Authors:  Aneley Getahun; Somsit Tansuphasawadikul; Varunee Desakorn; Jittima Dhitavat; Punnee Pitisuttithum
Journal:  J Med Assoc Thai       Date:  2006-09

6.  Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection.

Authors:  V G Valcour; P Sithinamsuwan; S Nidhinandana; S Thitivichianlert; S Ratto-Kim; W Apateerapong; B T Shiramizu; M S Desouza; S T Chitpatima; G Watt; T Chuenchitra; K R Robertson; R H Paul; J C McArthur; J H Kim; C M Shikuma
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

7.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.

Authors:  E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

Review 8.  Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.

Authors:  G J Moyle; M Sadler
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

9.  Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

Authors:  H Bacellar; A Muñoz; E N Miller; B A Cohen; D Besley; O A Selnes; J T Becker; J C McArthur
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

10.  Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine.

Authors:  K D Kieburtz; M Seidlin; J S Lambert; R Dolin; R Reichman; F Valentine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
View more
  6 in total

Review 1.  HIV-associated sensory neuropathy: risk factors and genetics.

Authors:  Peter R Kamerman; Antonia L Wadley; Catherine L Cherry
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 2.  Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications.

Authors:  Jean B Nachega; Maria Paola Trotta; Mark Nelson; Adriana Ammassari
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

3.  Translational research in NeuroAIDS: a neuroimmune pharmacology-related course.

Authors:  Amanda Brown; Bruce Shiramizu; Avindra Nath; Valerie Wojna
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-25       Impact factor: 4.147

4.  Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.

Authors:  Youngjee Choi; John Townend; Tim Vincent; Irfan Zaidi; Ramu Sarge-Njie; Assan Jaye; David B Clifford
Journal:  J Neurovirol       Date:  2011-03-22       Impact factor: 2.643

5.  Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia.

Authors:  Olivier Koole; Julie A Denison; Joris Menten; Sharon Tsui; Fred Wabwire-Mangen; Gideon Kwesigabo; Modest Mulenga; Andrew Auld; Simon Agolory; Ya Diul Mukadi; Eric van Praag; Kwasi Torpey; Seymour Williams; Jonathan Kaplan; Aaron Zee; David R Bangsberg; Robert Colebunders
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

6.  Prevalence and clinical characteristics associated with peripheral neuropathy amongst persons on HAART in Busia County, Kenya.

Authors:  John N Mukoma; Joseph M Matheri; Nassib Tawa
Journal:  S Afr J Physiother       Date:  2020-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.